 |
|
October 5, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Joseph Truitt, MBA, CEO & Board
Director, iECURE Inc. |
| In
this Q&A, Truitt discusses the UPenn
gene therapy data that led him to join
iECURE, the company's platform strategy of
using the PCSK9 locus as a genomic
"landing pad" for multiple pediatric liver
diseases, and early clinical evidence that
has shaped development of its lead
candidate. More |
|
|
- Establishment Labs: Receives FDA Approval
for Additional Sizes of Motiva Implants More
- Marea Therapeutics: First Patient Dosed in
Phase 2 Clinical Trial of MAR002, a Potential
Best-in-Disease Investigational Therapy for
the Treatment of Acromegaly More
- OnCusp Therapeutics: Positive Phase 1b Data
Evaluating its CDH6-Directed Antibody-Drug
Conjugate, CUSP06, in Platinum-Resistant
Ovarian Cancer (PROC) Presented at Plenary
Oral Session of the IGCS 2026 Annual Global
Meeting
More
- Pfizer: LITFULO Significantly
Improved Facial and Total Body
Repigmentation in Patients With Nonsegmental
Vitiligo More
More
More* More*
- SCIENTURE: Arbli(TM) Added to Formularies at
Three Leading U.S. Pediatric Academic Medical
Centers and Hospitals
More More
- The Rockefeller University: Hatching a New
Breed of Medicines
More
|
|
- Compass Pathways: New Employee Inducement
Grants Under Nasdaq Listing Rule 5635(c)(4) More
- Global Healthcare and Life Sciences – Q3
2026 Review More
- More on Kallyope Rebranding as Trigemx Bio,
Narrowing Focus to Migraine From Gut-Brain
Axis and Obesity Work More*
- Syndax Pharmaceuticals: Inducement Grants
Under NASDAQ Listing Rule 5635(c)(4) More
|
|
 |
| The
future of advanced therapies:
Explore challenges and
opportunities shaping patient
access, site-of-care expansion and
commercialization. |
| Access the
Report → |
|
|
- Astrazeneca and Daiichi Add Datroway to
Summit Cancer Collab More*
More*
More
- Big4Bio CEO Weekly Q&A: Joseph
Truitt, MBA, CEO & Board Director,
iECURE Inc. More
- Biotech Hangout: Episode 198 Podcast
- Introducing Fierce Biotech's 2026 Fierce 15
More
- More on Regeneron Highlighting Promising
Ovarian Cancer, Muscle Preservation Trial Data
More
- More on Regeneron Phase II Trial Confirming
Trevogrumab Halves Muscle Loss More*
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
 |
| Slone
Partners Places Farhad Ghavami as
Chief Executive Officer at
SeqCenter |
|
Learn More
→ |
|
|
- Butterfly Network: Appoints Mike Noonen to
Board of Directors More
- Chutes & Ladders—Bayer Taps New Chief
Medical Officer; Cantor Appointed PhRMA CEO More
- Insmed: CFO Transition More
- OPPORTUNITY: Director of Compliance - Remote
More
- OPPORTUNITY: Vice President, Business
Development - Remote More
- PMV Pharmaceuticals: Appoints Matt Eckler,
Ph.D., to Board of Directors More
- Slone Partners: Beyond the Org Chart
- Redefining Leadership Roles After an
Acquisition More
- TriGemX Bio: Strengthens Board of Directors
With Appointment of Doug Pagán More
|
|
 |
Events
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Biocom’s San Diego Life Science CEO
Summit Oct
8
- MassBioEd’s 25th Anniversary Gala Oct
21
- Biocom’s Bay Area CEO Summit Oct
23
- Biocom’s Greater LA CEO Summit Oct
27
- BioFuture Oct
27-28
- PODD: Partnership Opportunities in
Drug Delivery Oct
29-30
- Scaling Academic Research Programs
Through Strategic Colony Management
Partnerships Nov
11
- 23rd Annual Pantheon Awards
Nov 12
- 2026 LSPA Patient Summit Nov
12
- Patient Pathways (Use code 26B4B10
for 10% off) Nov
17-20
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
